ArticleAntibody therapeutics2025

Preclinical development of mecbotamab vedotin (BA3011), a novel, AXL-specific conditional active biologic antibody-drug conjugate.

Hwai Wen Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.